CS Paper Radar

Evidence-Bound Reasoning: Neuro-Semantic Verification of Biomedical AI in Glioblastoma Radiogenomics

Mariya Miteva, Maria Nisheva-Pavlova

cs.CL ·submitted 2026-10-06 16:44 UTC · v1
benchmark

Abstract

Background: Biomedical AI can generate plausible explanations without reliably verifying whether each statement is supported by patient-specific evidence. We developed a neuro-semantic verification framework that converts radiomic measurements into addressable evidence records and machine-checkable claims. Methods: UPenn-GBM radiomics were aligned with de novo CaPTk extraction from standardized MRI and expert-validated segmentations in an independent multicenter cohort. The shared space comprised 1,728 features from T1, T1GD, T2, and FLAIR MRI across three tumor regions. Reference-defined semantic states were derived from 611 UPenn cases. We evaluated cross-cohort transportability, model-linked provenance, deterministic verification, controlled predictive degradation, and an LLM claim-extraction pilot; MGMT prediction served only as a transport stress test. Results: Median semantic-state agreement was 0.786 (weighted kappa 0.709), ranging from 0.918 for morphologic to 0.252 for intensity features. The external evidence ledger contained 1,655 model-linked records for 331 patients. The verifier achieved 100% exact-set accuracy in a 6,620-claim corruption benchmark. In a 24-case pilot, GPT-5.6 Sol reproduced 72/72 prespecified atomic claims, and the frozen verifier recovered 24/24 expected conditions. During controlled degradation, ROC AUC declined from 0.899 to 0.500 while verification accuracy remained 1.000. External MGMT discrimination was weak (ROC AUC 0.543). Conclusions: Verifiability can be engineered and evaluated independently of predictive performance. LLMs may structure explanations, while final evidence-consistency checking remains deterministic.

Comment
15 pages, 4 figures, 4 tables. Preprint

Closest papers

Nearest neighbours by meaning across the whole index.

A Vision-Language Foundation Model for Precise and Comprehensive Brain Tumor Diagnosis from Preoperative Multimodal Data

cs.CV cs.AI ·2026-09-15 ·Yinong Wang, Jianwen Chen, Zhou Chen, Shuwen Kuang, Haoning Jiang +26 more
code/data similarity 0.69
Abstract · 94 pages, 22 Figures, supplement files, Project page link: https://hku-healthai.github.io/brainvlm_project.github.io/

We developed BrainVLM to classify all 12 World Health Organization (WHO) 2021 brain tumor types. BrainVLM integrates an uncertainty quantification strategy to indicate prediction reliability and a module for generating radiology reports to elucidate the clinical rationale. BrainVLM was trained on multi-modal data (MRI scans, demographics, and radiology reports) from 40,043 individuals. It was validated on 5,211 patients with pathologically confirmed brain tumors, including 3,877 held-out patients from the primary hospital and 1,334 patients from 11 independent hospitals. We further conducted two proof-of-concept studies to validate its clinical utility in AI-clinician workflows: 1) a blinded multireader study where 12 neuroradiologists across varying experience levels interpreted 248 retrospective cases with or without AI assistance, and 2) a real-world prospective study in which 1,009 patients were independently and blindly assessed by BrainVLM and radiologists before surgery. Additionally, we demonstrated BrainVLM's utility in preoperative molecular subgroup prediction for adult-type diffuse gliomas, using a multi-center cohort of 632 patients. In primary evaluation, BrainVLM achieved an area under the curve (macro-AUC) of 0.85 (95% CI: 0.84-0.86), and an F1 score of 0.82 (95% CI: 0.81-0.83), surpassing neuroradiologists (F1 = 0.80 (95% CI: 0.79-0.81)). In external validation across 11 centers, BrainVLM achieved an AUC = 0.80 (95% CI: 0.79-0.82) and F1 = 0.75 (95% CI: 0.73-0.78), compared with F1 = 0.71 (95% CI: 0.69-0.73) for neuroradiologists. In prospective real-world evaluation, BrainVLM maintained performance comparable to neuroradiologists. The BrainVLM project page is available at https://hku-healthai.github.io/brainvlm_project.github.io/.

0.35

The Diagnosis a Reporter Leaves Unspoken: Surfacing Frozen Tumor Features for Brain-Tumor MRI Reporting

cs.CV ·2026-09-02 ·Khawaja Murad ul Hassan, Ruqiyya Adil, Adil Qayyum, Rida Hassan, Asad Mansoor Khan +2 more
published similarity 0.68
Abstract · 10 pages, 2 figures, 3 tables. Accepted at MLCN 2026, a workshop held in conjunction with MICCAI 2026; to appear in Springer LNCS

A capable brain-MRI report generator can still be, in effect, diagnostically silent. When a multi-chain chain-of-thought (CoT) reporter built on a medical Mistral-7B backbone is evaluated on held-out cohorts, it names most meningiomas and almost all metastases "glioma" (diagnosis recall 0.44/0.07). Yet the answer is not absent from the model: a supervised linear probe applied to its frozen segmentation features recovers the three tumour cohorts at 0.82 macro-F$_1$ (5-fold cross-validation; chance $\approx$0.33). We introduce NeuroFusion, an assistive reporter that surfaces this latent signal rather than overriding it: discriminative field-classifier heads over per-lesion features condition a fast, single-pass draft-then-review decoder on their committed outputs. Built on the identical Mistral backbone, this restores the diagnosis (meningioma 0.92, metastasis 0.75) and wins 8 of 9 prose-content comparisons across three held-out cohorts (RaTEScore, RadGraph-F$_1$, GREEN; Holm-corrected paired BCa), with no significant loss on the ninth, at 5-6x lower latency ($\approx$80 vs. 457 s/case). A controlled negative result sharpens the mechanism: a learned diagnosis pin that overrides the decoder instead of merely informing it collapses out-of-distribution metastasis recall to 0.03. Grammar-constrained decoding keeps 92.3% of records schema-valid, making every sentence entailment-checkable (7.5% contradicted vs. 36.8% for the direct baseline). In a blinded nine-case pilot, two board-certified neurologists independently rated NeuroFusion highest in every tumour type, the only system with zero critical errors, and gave it the top-rated sign-off in eight of nine cases (six outright, two ties).

0.46

A Tumour-Aware Multimodal Framework for Explainable Prediction of IDH Mutation in Gliomas from Multi-Sequence MRI

eess.IV cs.CV ·2026-11-13 ·Tahsien Al-Quraishi, Waseem Alwan Zaboon, O. S. Albahri, Raza Nowrozy
similarity 0.67
Abstract · 45 pages, 12 figures, 4 tables. Preprint of an article submitted for consideration in International Journal of Information Technology & Deci…

Accurate prediction of isocitrate dehydrogenase (IDH) mutation status is essential for glioma diagnosis, prognosis, and treatment planning. Although recent deep learning approaches have demonstrated promising performance, many rely on whole-brain feature extraction and provide limited interpretability. This study proposes a tumour-aware multimodal framework for explainable, non-invasive prediction of IDH mutation status from multiparametric magnetic resonance imaging (MRI). The proposed framework integrates four MRI sequences (T1, T1CE, T2, and FLAIR), tumour subregion segmentation, quantitative radiomic descriptors, and clinical information within a unified deep learning architecture. An ablation study was conducted to evaluate the contribution of tumour-aware learning, radiomic features, and clinical variables. Model performance was assessed using multiple complementary evaluation metrics, including accuracy, precision, recall, F1-score, balanced accuracy, receiver operating characteristic analysis, confusion matrix evaluation, and Grad-CAM visualisation. Experimental results demonstrated that the proposed multimodal framework consistently outperformed the baseline MRI-only model, with the Clinical Fusion model achieving the strongest overall predictive performance. The integration of tumour-aware learning, radiomic descriptors, and clinical information progressively improved classification performance, while Grad-CAM visualisations indicated that the model predominantly focused on biologically relevant tumour regions. These findings suggest that tumour-aware multimodal feature integration enables accurate, interpretable, and non-invasive molecular profiling of gliomas and provides a promising foundation for future clinical decision support in precision neuro-oncology.

0.12

GliomaINK: A Tumor and Anatomy Conditioned Flow Matching Framework for 3D MRI Sequence Synthesis in Glioma Patients

eess.IV cs.CVq-bio.TO ·2026-10-16 ·Moinak Bhattacharya, Annie Singh, Mohammad Chaudhry, Prateek Prasanna, Gagandeep Singh
similarity 0.66
Abstract

Background: Incomplete multiparametric MR examinations limit glioma characterization and downstream AI tools. Generative models can synthesize missing MRI sequences, but anatomical structure and clinically relevant tumor features are challenging to preserve. We propose GliomaINK, an anatomy-guided conditional flow matching framework for cross-sequence 3D brain MRI synthesis. Methods: A 3D SwinUNETR predicted the conditional velocity field while an auxiliary topology-preserving loss encouraged structural consistency. The model was trained on 1,083 patients from the BraTS-AG dataset and independently tested on an in-house clinical cohort. Downstream tasks include image quality, tumor segmentation, IDH1 mutation-status prediction, and overall survival prediction. Two radiologists independently evaluated the anatomical fidelity, pathological representation, and overall image quality of the synthesized images. Results: GliomaINK exhibited the highest PSNR across all six MRI translation directions in both evaluation cohorts. In the BraTS-AG test set, the PSNR reached $25.64\pm0.55$ dB for the T2W-to-T1C synthesis, compared with $13.78\pm0.32$ dB for Pix2Pix and $18.90\pm0.53$ dB for SPADE. For downstream tumor segmentation, the method showed strong performance across tumor subregions with Dice scores reaching $0.928\pm0.014$ for edema, and $0.885\pm0.040$ for enhancing tumor. For the IDH1 mutation-status prediction, GliomaINK achieved the highest AUROC score in four of the six sequence configurations, reaching $0.827\pm0.088$. Conclusion: Anatomy-guided conditional flow matching enables high-fidelity cross-sequence glioma MRI synthesis demonstrating potential for preservation of clinically relevant information in synthesized MRI and improving downstream tasks.

0.18

An Accurate and Interpretable Hyper Graph Neural Network for GBM Survival Prediction

cs.AI cs.LG ·2026-09-19 ·Mushahid Intesum
position similarity 0.65
Abstract

Survival prediction for glioblastoma multiforme (GBM) demands models that are both accurate and interpretable, yet existing approaches treat these objectives as com- peting, where performant models sacrifice transparency, while interpretable models accept degraded predictive power. We argue that this trade-off is not inherent. Graph neural net- works offer a structural foundation for extracting interpretable, explainable representations without compromising discriminative ability. Furthermore, current methods typically rely on a single imaging modality, underutilizing the complementary information available across multi-modal MRI and clinical metadata. We propose a multi-modal framework that inte- grates three components to address both objectives simultaneously: (1) a sheaf hypergraph neural network that captures higher-order relationships among tissue patches through direc- tional, asymmetric message passing; (2) a concept bottleneck layer that compresses learned representations into clinically grounded concepts, enforcing ante-hoc interpretability; and (3) an extension sufficiency test (EST) regularizer that penalizes unfaithful explanations during training, ensuring that model explanations genuinely reflect the internal decision process. Clinical and genomic features are incorporated through gated fusion, preserving the dominant prognostic signal of molecular markers while retaining concept-level traceabil- ity. Evaluated on 593 patients from the UPenn-GBM dataset under 5-fold cross-validation, our framework achieves a concordance index of 0.643 with the lowest fold-level variance among all compared models (std = 0.015). To our knowledge, this is the first work to unify sheaf hypergraph convolution, concept bottleneck supervision, and EST regularization for interpretable survival prediction from brain MRI

0.19

Pathology Transport: Optimal-Transport Explanations for Clinical Data, and When Their Heatmaps (Fail to) Localize Disease

cs.LG ·2026-08-18 ·Lalit Kumar
benchmark similarity 0.64
Abstract

Generative models promise a route to explainable clinical AI: rather than probe a classifier, model the distributions of healthy and diseased patients and read explanations off the geometry between them. We build such a system - an optimal-transport rectified flow trained between two clinical distributions - and use it to ask a pointed question the field too rarely tests: do the resulting explanation heatmaps actually localize disease? On tabular tumour biomarkers (Breast Cancer Wisconsin) a single flow yields per-patient counterfactuals, an unsupervised malignancy score (AUROC 0.91; 0.93 +/- 0.01 across five seeds), and a label-free attribution that agrees with a supervised classifier (r ~ 0.5) - a compact, honest interpretability engine, though it never out-predicts logistic regression. Moving to chest X-rays, we show the transport heatmap is a population-level signal, not a localiser; a reconstruction-based, identity-preserving variant does localize synthetic lesions (pointing game 0.52), yet on real RSNA radiologist boxes it collapses to chance while only supervised Grad-CAM stays above it. The central result is a synthetic-to-real gap: label-free heatmaps that look compelling on planted lesions are not evidence of real localisation. We contribute a reusable optimal-transport recipe for generative explanations and a controlled benchmark for stress-testing whether they localize.

0.15

OpenBrain: An Auditable Generated-Label Release for Whole-Brain MRI Parcellation

cs.CV ·2026-11-03 ·Qizhen Lan, Yu-Chun Hsu, Yuxiang Wei, Lijing Zhu, Zenan Sun +3 more
top venuecode/data similarity 0.64
Abstract · Accepted at NeurIPS 2026, Evaluations and Datasets Track. Dataset: https://huggingface.co/datasets/lanqz7766/OpenBrain; code: https://github…

Automatic tools can now generate whole-brain MRI parcellations at cohort scale, but generated-label releases often provide little evidence about which cases are reliable enough to reuse. We introduce OpenBrain, a confidence-aware release of 35,838 provenance-verified OpenNeuro T1w cases from 607 source datasets. OpenBrain is organized as an auditable case-record release rather than a directory of standalone segmentation files: each record links a primary parcellation, two committee parcellations, source/license provenance, raw QC-7 measurements, percentile risks, a combined risk score R, and a confidence tier. QC-7 is a reference-free reliability panel over label geometry, image-label consistency, and committee disagreement, so users can filter, weight, audit, or re-threshold generated labels without rerunning inference. We evaluate this released evidence under a frozen protocol. Across external cohorts, lower QC-7 risk corresponds to higher generated-label quality; in fixed-budget training, lower-risk selections improve paired macro Dice over random selection by +3.2 to +3.7 percentage points. OpenBrain also exposes raw axes, committee outputs, provenance, and datasheet documentation, so confidence claims remain inspectable after download. It does not turn generated labels into manual annotations or clinical-grade segmentations. Its contribution is a large open generated-parcellation substrate, a reusable case-level risk-evidence layer, and an external validation protocol for release-time QC. Dataset: https://huggingface.co/datasets/lanqz7766/OpenBrain. Code: https://github.com/lanqz7766/openbrain.

0.44

Towards Trustworthy AI for Glioma Diagnosis: A Task-Aware Evaluation of Uncertainty Quantification

cs.CV cs.AI ·2026-09-30 ·Gonzalo Esteban Mosquera Rojas, Sebastian R. van der Voort, Carolin M. Pirkl, Sandeep Kaushik, Marion Smits +1 more
top venue similarity 0.64
Abstract · Accepted for publication at the Journal of Machine Learning for Biomedical Imaging (MELBA) https://melba-journal.org/2026:033

Uncertainty Quantification (UQ) is a key requirement for trustworthy AI in high-stakes medical image analysis. In this work, we evaluate UQ in a multi-task Deep Learning framework for MRI-based glioma diagnosis that performs tumor segmentation and predicts IDH mutation status, 1p/19q co-deletion status, and tumor grade. Monte Carlo Dropout (MCD) is used for a detailed task-aware analysis of predictive, aleatoric, and epistemic uncertainty. We assess MC sample convergence, calibration, error detection, selective prediction, associations with segmentation performance, and the effect of voxel-wise uncertainty aggregation on case-level reliability. We also compare MCD with Deep Ensembles (DE) and Monte Carlo Deep Ensembles (MCDE), examine interactions between segmentation quality and classification, and evaluate a composite trust score integrating segmentation and classification uncertainty. Across tasks, uncertainty estimates supported meaningful error detection, while calibration depended on the dropout rate, with moderate rates yielding the most reliable probabilities. Uncertainty decomposition provided task-dependent interpretability but did not consistently improve error detection over predictive uncertainty alone. DE and MCDE showed comparable operational utility, with no method consistently dominating across tasks and metrics. The composite trust score did not consistently outperform classification uncertainty for selective prediction. Overall, our results provide a task-aware evaluation strategy and practical guidance for the development of trustworthy AI for glioma diagnosis.

0.41